Category
19 stories · page 1 of 2
Skin
A source-led audit of Symrise’s new Lautier 1795 site, the EU’s expanded fragrance-allergen labels, and why natural does not automatically mean safer.
Aesthetics
Exosome serums and treatments promise regeneration. Early human studies are encouraging but small, and the US FDA says no exosome product is approved.
Skin
Clariant says Genadvance Revive uses styling heat as part of a hair-repair mechanism. We examine what its supplier tests measured, what independent hair-fibre studies establish, and why heat activation does not make high-temperature styling harmless.
Skin
Seppic’s Sepilife NEOS launch turns squalane into a formulation story. We separate verified launch facts from supplier performance claims, explain what ISO 16128 and EU microplastics rules do and do not establish, and list the evidence still missing.
Skin
Clariant’s new KanuFresh ingredient arrives with striking sweat, odour and irritation figures. LCY separates the verified launch facts from unpublished supplier evidence, regulation and real-world safety.
Science
A careful reading of the small company-linked OS-01 formula trial, including its multi-active design, skin reactions, conflicts of interest and need for independent replication.
Science
A precise comparison of cyclized hexapeptide-9 and a very low-dose retinol comparator—without turning one 56-day company-authored study into a class-wide verdict.
Science
Why plant- or biotech-derived nucleotide materials need analytical equivalence and product-specific human evidence before inheriting clinical PDRN claims.
Science
A new 2026 scoping review finds encouraging signals for topical exosomes but major heterogeneity and standardization gaps.
Science
Seven randomized trials with 183 participants span different products, routes and indications; injectable findings cannot be transferred to retail topicals.
Technology
A new color-science collaboration targets better complexion matching. The research question is important—but the announcement is not yet a validation result.
Skin
Why an ingredient name alone cannot prove a skincare result, and how LCY compares concentration, formulation, finished-product evidence, safety and claim scope.
